Ronald M. Kurtz MD - 05 Sep 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Reporting relationship: Chief Medical Officer
Issuer ticker: RXST
Reported as of: 05 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Sep 2026, 20:53:51 UTC
Prior SEC filing: 02 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Jim Schindler, as Attorney-in-Fact

Filing notes and source

Key filing fact

Ronald M. Kurtz MD filed Form 4 for RxSight, Inc. (RXST) on 09 Sep 2026.

Key facts

This page summarizes Ronald M. Kurtz MD's Form 4 filing for RxSight, Inc. (RXST).
8 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 09 Sep 2026, 20:53.

Change

Previous filing in this sequence was filed on 02 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001295469 Primary reporting owner

Kurtz Ronald M MD

Relationship: Chief Medical Officer
Address: C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO
Signature: /s/ Jim Schindler, as Attorney-in-Fact
Signature date: 09 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Stock option (right to buy)

Disposed to Issuer

Transaction value
Shares: -338,819
Change %: -100%
Price
Shares after: 0
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 338,819
Exercise price: $16.00
Footnotes: F1

RXST transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -200,000
Change %: -100%
Price
Shares after: 0
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price: $14.95
Footnotes: F2, F3

RXST transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -149,000
Change %: -100%
Price
Shares after: 0
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 149,000
Exercise price: $56.07
Footnotes: F4, F5

RXST transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -215,000
Change %: -100%
Price
Shares after: 0
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 215,000
Exercise price: $28.21
Footnotes: F1, F6

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +254,751
Change %
Price
Shares after: 254,751
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 254,751
Exercise price: $6.38
Footnotes: F1, F7

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +173,913
Change %
Price
Shares after: 173,913
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 173,913
Exercise price: $6.38
Footnotes: F3, F8

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +96,129
Change %
Price
Shares after: 96,129
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 96,129
Exercise price: $6.38
Footnotes: F5, F9

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +161,654
Change %
Price
Shares after: 161,654
Date: 05 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 161,654
Exercise price: $6.38
Footnotes: F1, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.

Footnote F2

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.

Footnote F3

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share.

Footnote F4

Footnote F5

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share.

Footnote F6

Footnote F7

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.

Footnote F8

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Footnote F9

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Footnote F10

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.